title: Evaluation and treatment of erectile dysfunction in the aging male: a mini-review.
abstract: Before the 20th century, individuals often did not live beyond the reproductive years, and sexuality of the elderly was not an issue. However, in the current era it is known that as life expectancy improves, both men and women are seeking to preserve their sexuality into old age. While the appreciation of sexuality persists with aging, a decline in sexual activity is typically seen with, and can be attributed to both general health problems as well as specific sexual dysfunctions. Erectile dysfunction is the most frequently diagnosed sexual dysfunction in the older male population. This mini-review provides an overview of contemporary literature concerning epidemiology, pathophysiology, assessment and treatment of erectile dysfunction in the aging male.
authors.affiliation: Department of Urology, University of California at San Francisco, San Francisco, CA, USA. Maarten.albersen@uzleuven.be
authors.forename: Maarten
authors.initials: M
authors.lastname: Albersen
authors.forename: Hazem
authors.initials: H
authors.lastname: Orabi
authors.forename: Tom F
authors.initials: TF
authors.lastname: Lue
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000502:physiology; D001058:Apomorphine / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D028321:Plant Preparations / Q000627:therapeutic use; D019736:Prostheses and Implants; D014618:Vacuum
chemical_list: D058986:Phosphodiesterase 5 Inhibitors; D028321:Plant Preparations; D001058:Apomorphine